Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors
- Wayne L. Furman
- , Fariba Navid
- , Najat C. Daw
- , M. Beth McCarville
- , Lisa M. McGregor
- , Sheri L. Spunt
- , Carlos Rodriguez-Galindo
- , John C. Panetta
- , Kristine R. Crews
- , Jianrong Wu
- , Amar J. Gajjar
- , Peter J. Houghton
- , Victor M. Santana
- , Clinton F. Stewart
Research output: Contribution to journal › Article › peer-review
48
Link opens in a new tab
Scopus
citations